Or call 888-224-2480 for fastest service.

You can save extra 10% off the current rate by using code D10-999-JDS23.

Biologics have become the fastest-growing class of therapeutic compounds. They have provided innovative treatment alternatives for people who suffer from some of the most serious medical conditions known to man. The incorporation of biosimilar products into the U.S. marketplace was designed to improve patient access and decrease healthcare costs. While much has evolved since the enactment of the BPCIA, the traditional barriers remain.

Now, more than ever, strategies to overcome these barriers are essential to improve the understanding of biosimilar products in the United States. The need for a solid guiding framework becomes more critical than ever before.

Hosted by ACI, 14^th Summit on Biosimilars & Innovator Biologics returns for another exciting year with curated programming that will provide the critical updates you need to prepare for the considerable changes that will take place in the next year around the scope of products that are regulated and litigated.

CONFERENCE CO-CHAIRS

Join the “who’s who” of the biosimilars and innovator biologics industries as they gather virtually to discuss and contemplate the impact of these critical developments.

With the current and future uncertainties, a wide range of market outcomes are possible. Join the faculty of global thought-leaders at this groundbreaking event to discuss legal, regulatory, and commercial strategies for the innovator and biosimilars marketplace that are essential to the proliferation of these products.

AJP INSIGHTS FROM

Save 10% off the current registration fee by using code D10-999-JDS23.

*Discount is valid for new registrations only and it’s not applicable for workshops.